News

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Astrazeneca Pharma India announced that Jes�s Diaz-Ropero Esteso has resigned from the position of Non-Executive Director of AstraZeneca Pharma India and consequently from the Board Committee(s) on which he served, with immediate effect, due to a transition from current responsibilities. Powered by Capital Market - Live News

The board of Astrazeneca Pharma India has appointed Sandhya Tejaswini Amanna as Director - Legal, with effect from 18 March 2026.Powered by Capital Market - Live News

Net profit of Astrazeneca Pharma India rose 5.64% to Rs 32.59 crore in the quarter ended December 2025 as against Rs 30.85 crore during the previous quarter ended December 2024. Sales rose 38.90% to Rs 611.57 crore in the quarter ended December 2025 as against Rs 440.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales611.57440.29 39 OPM %7.3317.49 - PBDT48.9084.64 -42 PBT45.0675.57 -40 NP32.5930.85 6 Powered by Capital Market - Live News

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News